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Long-termtreatmentwithceftriaxoneattenuatesthereinstatementofcocaineseekingwhile increasingthefunctionoftheglutamatetransporter
1 (GLT-1) andsystemxC- (Sxc) in thenucleusaccumbenscore (NAc). Sxc contributes themajorityofnonsynaptic extracellular glutamate in the
NAc, while GLT-1 is responsible for themajority of glutamate uptake. Here we used antisense to decrease the expression of GLT-1 and xCT (a
catalytic subunit of Sxc) to determine the relative importance of both proteins in mediating the ability of ceftriaxone to prevent cue-induced
reinstatement of cocaine seeking and normalize glutamatergic proteins in the NAc of rats. Intra-NAc xCT knockdown prevented ceftriaxone
from attenuating reinstatement and fromupregulating GLT-1 and resulted in increased surface expression of AMPA receptor subunits GluA1
and GluA2. Intra-NAc GLT-1 knockdown also prevented ceftriaxone from attenuating reinstatement and from upregulating xCT expression,
without affecting GluA1 and GluA2 expression. In the absence of cocaine or ceftriaxone treatment, xCT knockdown in the NAc increased the
expressionof bothGluA1andGluA2without affectingGLT-1 expressionwhileGLT-1knockdownhadnoeffect. PCRand immunoprecipitation
of GLT-1 revealed that ceftriaxone does not upregulate GLT-1 and xCT through a transcriptionalmechanism, and their coregulation by ceftri-
axone is notmediated by physical interaction. These data support important and distinct roles for xCT andGLT-1 in the actions of ceftriaxone
and add to a bodyof literature finding evidence for coregulation of these transporters. Our results also point to xCT expression and subsequent
basal glutamate levels as being a keymediator of AMPA receptor expression in theNAc.
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Introduction
Cocaine (Coc) addiction is a chronic disease that is characterized
by an inability to regulate drug seeking, resulting in a high rate of
relapse (O’Brien, 2003). Relapse is modeled in animals with the
self-administration and reinstatement paradigm, where a drug-
reinforced response is extinguished and reinstatedwith one of the
stimuli that causes relapse in humans (e.g., a drug-associated cue;
Epstein et al., 2006). Glutamate efflux in the nucleus accumbens
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Significance Statement
Ceftriaxone attenuates the reinstatement of cocaine, alcohol, and heroin seeking. Themechanism of action of this behavioral effect has
beenattributed toglutamate transporter1 (GLT-1)andxCT(acatalytic subunitof Sxc)/Sxcupregulation in thenucleusaccumbenscore.
Here we used an antisense strategy to knock down GLT-1 or xCT in the nucleus accumbens core and examined the behavioral and
molecular consequences.While upregulation of both xCT andGLT-1 are essential to the ability of ceftriaxone to attenuate cue-induced
reinstatement of cocaine seeking, eachproteinuniquely affects the expressionof other glutamate receptor and transporter proteins.We
also report that reducing basal glutamate levels through themanipulation of xCT expression increases the surface expression of AMPA
receptor subunits, providing insight to themechanismbywhich cocaine alters AMPA surface expression.
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core (NAc) accompanies the reinstatement of cocaine seeking
prompted by cues, cocaine, and context (McFarland et al., 2003;
LaCrosse et al., 2016; Smith et al., 2017). Accordingly, the antag-
onismofNAcAMPA (Cornish andKalivas, 2000; Xie et al., 2012)
andmGlu5 receptors (Wang et al., 2013) attenuates the reinstate-
ment of cocaine seeking.
Several NAc adaptations occur 2–3 weeks after cocaine ad-
ministration that facilitate an increase in glutamate efflux during
reinstatement (for review, see Mulholland et al., 2016). System
xc- (Sxc) contributes themajority of extracellular basal glutamate
in theNac, and its function is decreased following cocaine admin-
istration (Baker et al., 2002, 2003), likely leading to a loss of tone
on mGlu2/3 autoreceptors (Moussawi et al., 2011). Glutamate
reuptake is also disrupted by cocaine. The glial glutamate trans-
porter 1 (GLT-1) is responsible for 90% of all CNS uptake
(Haugeto et al., 1996; Tanaka et al., 1997), and its expression and
function are decreased in the NAc of cocaine-extinguished ani-
mals (Knackstedt et al., 2010a).
Postsynaptic adaptations are also observed in theNAc 2–3weeks
following cocaine administration. Cocaine self-administration and
extinction training results in an inability to induce LTP by stimulat-
ing PFC afferents to the NAc, indicating that these neurons are al-
ready in an LTP-like state (Moussawi et al., 2009). We previously
observed a potentiation of both spontaneous EPSCs (sEPSCs) and
evoked EPSCs in the NAc of rats that were extinguished from co-
caine self-administration (Trantham-Davidson et al., 2012).
Chronic treatment with the antibiotic ceftriaxone (Cef) in-
creases NAc expression of GLT-1 and xCT (the catalytic subunit
of Sxc) and attenuates the reinstatement of cocaine seeking (Sari
et al., 2009; Knackstedt et al., 2010a). We have shown that Cef
increases basal extracellular glutamate in the NAc via increased
Sxc activity and also prevents glutamate efflux during reinstate-
ment of cocaine seeking (Trantham-Davidson et al., 2012). Cef
also normalizes potentiated evoked EPSC and sEPSC amplitude
observed following cocaine (Trantham-Davidson et al., 2012).
We previously determined that following abstinence from co-
caine (without extinction), the expression of the AMPA subunit
GluA1 is increased and Cef normalizes this expression (LaCrosse
et al., 2016).
The present work is aimed at understanding the relative im-
portance of xCT and GLT-1 upregulation in mediating the
ability of ceftriaxone to attenuate cue-primed reinstatement of
cocaine seeking and normalize the NAc glutamatergic synapse.
Acute intra-NAc treatment with aGLT-1 antagonist prevents Cef
from attenuating cue-primed reinstatement (Fischer et al., 2013).
Because Cef is administered chronically and exerts long-lasting
changes in glutamate homeostasis (Sondheimer and Knackstedt,
2011), we used an antisense (AS) strategy to prevent GLT-1 or
xCT upregulation for the duration of Cef treatment to under-
stand how preventing such upregulation by Cef dysregulates the
NAc synapse.
We tested the hypothesis that the restoration of basal extra-
cellular glutamate by Cef underlies its ability to normalize synap-
tic strength through modifying AMPA receptor expression.
GluA1 is increased in NAc synaptosomes (Ghasemzadeh et al.,
2009) but not in the postsynaptic density (Knackstedt et al.,
2010b) following extinction from cocaine self-administration.
Further, NAc GluA2 total expression is increased following 30 d
of abstinence from cocaine (Lu et al., 2003). Here we examined
surfaceGluA1 andGluA2 expression, as thismeasure likely aligns
closely with physiological measures. Finally, as cocaine and alco-
hol consumption downregulate, while Cef and N-acetylcysteine
upregulate both xCT and GLT-1 expression (Knackstedt et al.,
2010a; Alhaddad et al., 2014; Rao and Sari, 2014), we tested the
hypothesis that the expression of these proteins is coregulated.
Pharmacological evidence for coregulation of these proteins has
been demonstrated in cell culture (Bannai, 1986; Murphy et al.,
1989), and here we are the first to investigate coregulation in vivo.
Materials andMethods
Animals
Two hundred forty-three adult male Sprague Dawley rats (Charles River
Laboratories) weighing 275–300 g were single housed in a temperature-
and humidity-controlled vivarium on a reversed 12 h light/dark cycle
with water available ad libitum. Animals were food restricted to eating
20–25 g of standard rat chow per day. All animal procedures were ap-
proved by the institutional animal care and use committee of the Uni-
versity of Florida (Experiments 1–6) or theUniversity ofNorthCarolina,
Chapel Hill (Experiment 7) and were performed in accordance with the
Guide for the Care and Use of Laboratory Animals.
Catheter and stereotaxic surgery
Animals were anesthetized using amixture of ketamine (87.5mg/kg, i.p.)
and xylazine (5 mg/kg, i.p.) and surgically implanted with jugular vein
catheters. Ketorolac (2 mg/kg, i.p.) was administered preoperatively for
pain. Catheters (SILASTIC silicon tubing [inner diameter (i.d.), 0.51
mm; outer diameter, 0.94 mm, Dow Corning] were implanted in the
right jugular vein, secured with sutures, and then passed subcutaneously
between the shoulder blades to exit though the skin on the back. The
catheter was then attached to a stainless steel cannula that was held stable
within a harness (Instech). For the implantation of guide cannulae, rats
were placed in a stereotaxic frame (Stoelting), and stainless steel guide
cannulae for antisense infusion (26 gauge; Plastics One) or microdialysis
(22 gauge; Synaptech) were aimed at the NAc according to the following
coordinates (anteroposterior,1.2 mm;mediolateral,1.6 mm; dorso-
ventral,5.5mm;Paxinos andWatson, 2005). Cannulaewere secured to
the skull with stainless steel skull screws and dental acrylic (Co-Oral-Ite
DentalMFG). Animals received 0.3ml of ketorolac (2mg/kg, i.p.) for 3 d
postoperatively for treatment of pain. The antibiotic cefazolin (100 mg/
ml) was administered via catheter for 7 d and followed by 0.1 ml of
heparinized saline (Sal; 100 U/ml). Catheters were flushed with 0.1 ml of
heparinized saline (100 U/ml) before and after each self-administration
session to ensure continued catheter patency. Animals were allowed to
recover for 5 d before self-administration procedures were initiated. Cathe-
ter patencywas verified periodically viamethohexital sodium(10mg/ml; Eli
Lilly).
Cocaine self-administration and extinction procedures
Animals were trained to self-administer cocaine under an FR-1 schedule
of reinforcement in standard operant chambers (30 24 30 cm; Med
Associates) equipped with two retractable levers. Presses on the active
lever resulted in an intravenous infusion of cocaine (0.33mg/infusion for
Experiments 1–3,6; 0.2 mg/infusion for Experiment 7), and the presen-
tation of auditory (2900 Hz tone) and visual (stimulus light) cues. Co-
caine hydrochloride was generously donated by theNational Institute on
Drug Abuse Controlled Substances Program (Research Triangle Insti-
tute). Each infusion of cocaine was followed by a 20 s “time-out” period,
during which time presses on the active lever did not yield drug. Presses
on the inactive lever were recorded but not reinforced. Animals main-
tained daily 2 h self-administration sessions until a criterion of 10
infusions of cocaine/session for 12 d was attained. Upon reaching the
criterion, animals began extinction training, during which time presses
on the lever that previously yielded cocaine and cues no longer did so.
During extinction training, some rats were treated with Cef (200 mg/kg,
i.p.) or vehicle (Veh; 0.9% physiological saline, 1 ml/kg, i.p.) and Mor-
pholino oligos, as described below for each experiment.
Antisense-mediated knockdown of GLT-1 and xCT
Antisense Vivo-Morpholino oligos (Gene Tools) were designed to inter-
fere with the translation of xCT and GLT-1 using sequences described
previously (Reissner et al., 2012). The GLT-1 oligo was designed against
a sequence that would knock down all isoforms ofGLT-1, which differ by
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C-terminal sequence. A negative control (Ctrl) oligo was used with the
following sequence: CCTCTTACCTCAGTTACAATTTATA. All oligos
were dilutedwith sterile PBS and injected bilaterally at a concentration of
30 pmol/side in 1l. Formicroinjections, 33 gaugemicroinjectors (Plas-
tics One) extended 2 mm beyond the tip of the cannulae, and injections
were administered at the rate of 0.5 l/min using an infusion pump
(Harvard Apparatus). Injections occurred daily for 3 d, ending precisely
7 d before the reinstatement test or being killed (Fig. 1A). Previous data
showed that maximal xCT and GLT-1 downregulation occurred at this
time after this injection regimen (Reissner et al., 2012).
Histology
Accurate cannulae placement was confirmed for Experiments 1, 2, and 5
using cresyl violet staining following trans-cardial perfusion with 0.9%
saline. The brains were removed and stored in 10% formalin for at least
24 h. Coronal sections (200 m thick) were mounted on slides and
stained with cresyl violet. Cannulae placement was determined using a
rat brain atlas (Paxinos and Watson, 2007). Only rats with cannulae
placement inside the NAc are included in the data presented here.
Experimental procedures
Experiments 1 and 2.Rats self-administered co-
caine as described above. During extinction
training, rats received bilateral intra-NAc infu-
sions of antisense targeting xCT, GLT-1, or
control oligo as described above. Rats received
either Cef or Veh immediately after extinction
sessions for the last 6 d of extinction training
before cue-primed reinstatement testing ac-
cording to the timeline in Figure 1A. Rats that
did not extinguish lever pressing by 7 d follow-
ing the last morpholino infusion were not
tested for reinstatement. Successful extinction
was defined as an average of20 presses on the
previously active lever for the 2 days immedi-
ately preceding reinstatement testing. During
cue-primed reinstatement tests, presses on the
previously active lever once again yielded the dis-
crete cues paired with drug delivery but no drug.
Rats received a single 2 h reinstatement session.
Outliers and rats excluded for not meeting self-
administration or extinction criteria are detailed
in the Results section.
Experiments 3 and 4: surface receptor and to-
tal protein assessment of GluA1, GluA2, xCT,
and GLT-1 following xCT or GLT-1 antisense
infusion. For Experiment 3, rats underwent co-
caine self-administration. During extinction
training, rats received bilateral intra-NAc infu-
sions of antisense targeting xCT, GLT-1, or
control antisense as described above and in
Figure 1A. Rats received either Cef or Veh im-
mediately after extinction sessions for the last
6 d of extinction training before being killed for
biotinylation/Western blotting without a rein-
statement test (Fig. 1A). For Experiment 4,
cocaine-naive rats received intra-NAc infu-
sions of xCT or GLT-1 antisense or control oli-
gos and were killed 7 d after the last antisense
infusion.
We conducted biotinylation of surface pro-
teins as reported previously (Knackstedt et al.,
2010b). Rats were killed via rapid decapitation,
and the NAc was dissected on ice and sliced
with aMcIllwain tissue chopper (Ted Pella). In
Experiment 4, the presence of cannula tracks in
acute NAc slices was visually verified. Slices
were incubated in Sulfo-NHS-SS-Biotin (1
mg/ml; Pierce), and the reaction was quenched
by glycine. A portion of the sample lysate was
incubated with streptavidin agarose beads (ThermoFisher Scientific).
The remainder of the sample was stored as the total protein fraction.
Biotinylated proteins attached to streptavidin-coated beads were sepa-
rated by centrifugation and eluted with Laemmli buffer.Wewere limited
to the processing of 12 samples/day. Because the conditions (e.g., biotin
lot number) could potentially affect the degree of biotinylation, 4–5
Sal-Veh-Ctrl rats were included in each biotinylation cohort for the stan-
dardization of Western blot results against this group. The amount of
GluA1 and GluA2 protein in the total and biotinylation fractions was
analyzed by quantitative Western blotting as described below. GLT-1,
GLT-1a, and xCT were blotted only in the total protein fraction.
Proteins were separated using 10% SDS-PAGE and transferred to
PVDF membrane. The membranes were probed overnight at 4°C with
primary antibodies diluted in 5% milk/Tris-buffered saline with 0.1%
Tween-20. After incubation with HRP-conjugated secondary antiserum
(Jackson Immunoresearch), immunoreactive bands on the membranes
were detected by enhanced chemiluminescence (ECL Plus, GE Health-
care Bio-Sciences). Band density was measured using ImageJ software
(National Institutes of Health). For total protein expression, blots were
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Figure 1. Self-administration, extinction, and reinstatement lever pressing in rats receiving intranucleus accumbens core AS
directed at xCTor Ctrl oligo andCef or Veh.A, Timeline for the experiments yielding thedatagraphed in Figures 1, 2, and3.B, Active
lever presses during self-administration and extinction. C, Inactive lever pressing during self-administration and extinction. D,
Active lever pressingduring the last 2dof extinction (mean) andduringa cue-primed reinstatement test. Reinstatementof cocaine
seeking is defined as a significant increase in active lever pressing fromextinction to test. The knockdownof xCT blocked the ability
of Cef to prevent reinstatement. *p 0.05 comparing extinction to cue test (n 7–12/group, indicated in D). E, Inactive lever
presses did not differ by group or test. F, A subset of the correct placements are noted here as examples of the total of 40 bilateral
cannulae locations.
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reprobedwith calnexin as a loading control. Antibodies and dilutions are
presented in Table 1.
Experiment 5: no-net-flux microdialysis and HPLC assessment of basal
extracellular glutamate following xCT knockdown in cocaine-naive rats.
Cocaine-naive rats were used to determine whether xCT antisense al-
tered basal extracellular glutamate in the NAc. Seven days following the
last injection of Ctrl (n  8) or xCT antisense (n  9), microdialysis
probes (2mm cuprophanemembranes, Synaptech) were implanted into
the NAc. Probes were perfused overnight with aCSF containing 125 mM
NaCl, 2.5 mM KCl, 1 mM MgCl26H2O, 5 mM D-glucose, and 1.2 mM
CaCl2H2O in 0.75ml of PBS. For no-net flux dialysis, increasing concen-
trations of glutamate (0, 2.5, 5, and 10 M) were perfused and the efflux
was collected at 20min intervals for 80min. Liquid switches were used to
minimize the pressure fluctuationswhile changing buffers. The first sam-
ple collected after switching to a new glutamate concentration was
discarded.
Glutamate was quantified in dialysate samples using isocratic high-
performance liquid chromatography (HPLC) with electrochemical detec-
tion (ThermoFisher Scientific).Microdialysis samples were derivatizedwith
o-pthalaldehyde (Sigma-Aldrich) by an autosampler (ThermoFisher Scien-
tific) immediately before injection onto a CAPLCELL PAK C18 column
(5m,2.0mmi.d.,50mm;Shiseido).Themobilephase consistedof100mM
Na2HPO4, 16%(v/v)methanol, and2.5%(v/v) acetonitrile, pH6.5.Glutamate
levels in thedialysis sampleswerequantifiedbycomparingcomputer-integrated
peak areas of sampleswith those of L-glutamate standards.
Experiment 6: RT-PCR assessment of GLT-1 and xCT following cocaine
self-administration and ceftriaxone treatment. Rats underwent cocaine
self-administration and extinction training as described above. Follow-
ing 2 weeks of extinction training, rats were killed via rapid decapitation
and the NAc was dissected and frozen at 80°C. One hemisphere was
used for quantitative PCR (qPCR) analysis, and the other for Western
blotting. For qPCR, total RNA was extracted from tissue using the
RNeasy Mini Kit (Qiagen) according to manufacturer instructions. The
cDNA was synthesized using a High-Capacity cDNA Reverse Transcrip-
tionKit (Applied Biosystems) using 10l of total RNA. The SYBR-Green
primer pairs were pooled and diluted to a final concentration of 200 nM
and were combined with SYBR-GreenMasterMix (Applied Biosystems)
and cDNA for the preamplification PCR. The PCR cycles were as follows:
1 cycle of denaturing at 95°C for 10 min, then 14 cycles at 95°C for 15 s
and annealing at 60°C for 1 min. Preamplified samples were diluted and
stored at20°C. SYBR-GreenQuantitative RT-PCRs were performed in
triplicate on a SteponePlus machine (Applied Biosystems). For each re-
action, 3l of cDNA (1:5 diluted) was placed in a 20l reaction contain-
ing 10l of SYBR-Green PCRMasterMix (Applied Biosystems) and 200
nM final concentration of each primer (ThermoFisher Scientific). The
primers used were previously described (O’Donovan et al., 2015) and are
shown in Table 2. Reactions were performed with an initial ramp time of
3 min at 95°C, and 50–60 subsequent cycles of 15 s were performed at
95°C and for 1min at the annealing temperature of 59°C. In all, 60 cycles
were used for GLT-1b, and 50 cycles were used for all other primer sets.
For negative controls for the quantitative RT-PCRs, cDNA was omitted.
Relative concentrations of the transcripts of interest were calculated with
comparison to a standard curve made with dilutions of cDNA from a
pooled sampling of all the subjects. Values for the transcripts of interest
were normalized to the geometric mean of 18 s, -actin, GAPDH, and
cyclophilin A values for the same samples. Western blotting was con-
ducted in the second hemisphere for xCT, GLT-1a, and GLT-1b as de-
scribed above for Experiments 3 and 4. Antibody concentrations are
detailed in Table 1.
Experiment 7: coimmunoprecipitation of GLT-1. Animals were rapidly
decapitated, and bilateral NAc tissue was dissected on ice. Tissue was
homogenized in 400l of homogenization buffer containing 20mMTris
Cl, pH 7.4, 140mMNaCl, 1% Triton X-100, and 1:100 protease inhibitor
cocktail with EDTA (catalog #1862209, ThermoFisher Scientific). Sam-
ples were homogenized using a sonicator, using two 5 s pulses. Lysates
were centrifuged at 1000 g for 10 min, and protein content was deter-
mined by BCA assay (ThermoFisher Scientific). Protein A/G agarose
(catalog #20421, ThermoFisher Scientific) was equilibrated in homoge-
nization buffer, and 1.2mgof lysatewas precleared for 1 h at 4°C in a final
volume of 500 l containing 50% protein A/G agarose. Precleared lysate
(500 g) was then added to 10 g of antibody (either anti-GLT-1 (cata-
log #ABN102, EMD Millipore) or negative control rabbit IgG (catalog
#10500C, Life Technologies) and conjugated overnight at 4°Cwith gentle
rotation. The next day, 100 l of 50% beads equilibrated in homogeni-
zation buffer was added to each tube and rotated for 2 h at 4°C. Beads
were then washed three times in homogenization buffer plus protease
inhibitors, and samples were eluted in 35 l of 4 Laemmli protein
sample buffer containing 5%-mercaptoethanol andheated at 100°C for
10min followed by vortexing. Eluted samples were separated from beads
by centrifugation and stored at 20°C. Western blotting for Na/K-
ATPase subunit 3, GLT-1, and xCT was conducted as described above
and in Table 1.
Statistical analysis
GraphPad Prism (version 6.00, GraphPad Software) was used for statis-
tical analyses with the  level set at p  0.05. Active and inactive lever
pressing during self-administration and extinction training was analyzed
with mixed-factorial two-way ANOVAs, with group and time as factors,
and repeated-measures (RM) ANOVA conducted on time. Active and
inactive lever pressing during reinstatement tests were analyzed with
mixed-factorial group test two-way ANOVAs, with group and test as
factors and repeated-measures ANOVA conducted on test. Significant
main effects and interactions detected by two-way RM ANOVAs were
followed by Sidak’s post hoc analyses to examine differences in group or
time/test. Immunoblotting data, represented by integrated density of
individual protein bands, was normalized for the density of calnexin
Table 1. Antibodies used for western blotting
Antibody Company Catalog number Lot number Concentration RRID
Rabbit anti-Calnexin Millipore AB2301 2587261 1:40000 AB_11210810
Rabbit anti beta-tubulin Abcam ab6046 GR251141-1 1:80000 AB_2210370
Guinea Pig anti-GLT1a Millipore AB1783 2234155 1:20000 AB_90949
Rabbit anti-GLT1b Paul Rosenberg, Harvard 1:50000
Rabbit anti-nGLT1 Paul Rosenberg, Harvard 1:2000
Rabbit anti-GLT1a Paul Rosenberg, Harvard 1:80000
Rabbit anti-xCT Novus NB300-318 I-01 1:5000 AB_10000581
Mouse anti-GluA1 Millipore MAB2263 2428724 1:2000 AB_1977459
Rabbit anti-GluA2 Abcam ab20673 GR117410-1 1:2000 AB_2232655
Rabbit anti-3 Abcam ab2826 GR256755-6 1:3000 AB_2258740
Table 2. SYBR-Green primer sequences
Primer Forward Reverse
-actin AGTACTCTGTGTGGATCGGT GCTGATCCACATCTGCTGGA
18S CGCCGCTAGAGGTGAAATTC TTGGCAAATGCTTTCGCTC
cyclophilinA CTCCTTTGAGCTGTTTGCAG CACCACATGCTTGCCATCC
GAPDH GACATGCCGCCTGGAGAAACC GACAATGAATATGGCTACAGC
GLT-1 CCAGTGCTGGAACTTTGCCT TAAAGGGCTGTACCATCCAT
GLT-1b GGACAGGATGAGAACTTCAGTCAA ACAAGTCTCGATATCCATGAATGG
xCT CCCAGATATGCATCGTCCTT ACAACCATGAAGAGGCAGGT
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immunoreactivity within the same sample. The treatment groups were
normalized to the Sal-Veh-Ctrl group, and this value was compared
between groups using one-way ANOVAs and Sidak’s post hoc tests. For
the no-net-fluxmicrodialysis experiment, we first subtracted the concen-
tration of Glu added to the perfusate from the amount measured in the
dialysate ([Glu]in  [Glu]out). These values were plotted against the
[Glu]in, and a line of regression was drawn. The x-intercept reflects basal
glutamate concentration, and we examined group differences in this
measure using an independent-samples t test. The slope of the line of
regression reflects the extraction fraction, and thus the slopes were com-
pared between groups using an independent-samples t test. PCR data
were tested for normal distribution using the D’Agostino and Pearson
omnibus normality test. Data were analyzed using one-way ANOVA and
presented as the mean SEM.
Results
Cocaine self-administration
For all experiments, assignments to receive antisense and Cef or
Veh were made following the completion of self-administration
such that there were no group differences in the number of
infusions, or inactive and active lever presses throughout self-
administration. A number of rats were eliminated during the
self-administration portion of the experiment due to a loss of
catheter patency (n  6), illness (n  2), or failure to acquire
self-administration (n 19). Four rats were excluded for cannu-
lae placements outside of the NAc (two rats each in Experiment 1
and Experiment 2), and three rats were excluded for failing to
meet extinction criteria (Experiment 1). One rat was excluded
due to a preference for the inactive lever over the active lever
throughout self-administration (Experiment 3), and one rat dis-
played active lever pressing during reinstatement that was 2
SDs from the mean (Experiment 1). There were four outliers in
Experiment 5 that are described below. Data from the remaining
203 rats are included in the results below, and the number of
rats/group are detailed in the figures.
Experiment 1: xCT knockdown inhibits the prevention of
reinstatement by ceftriaxone
Rats self-administered cocaine for 12 d and then underwent ex-
tinction training. Following 1 week of extinction training, rats
were treatedwith a Ctrl oligo or AS oligo designed to knock down
xCT such that the target protein would be suppressed on rein-
statement day, as optimized previously (Reissner et al., 2012).
Rats were also treated with Veh or Cef, according to the timeline
in Figure 1A. Presses on the previously active lever increased on
day 1 of extinction and then decreased over the course of extinc-
tion training (Fig. 1B). Presses on the inactive lever remained low
throughout self-administration and extinction (Fig. 1C).
A two-way RM ANOVA conducted on active lever pressing
during the last 2 d of extinction and the cue-primed reinstate-
ment test indicated a significant effect of test (F(1,35) 43.15, p
0.001) but no effect of group and no test group interaction. As
the definition of “reinstatement” is the resumption of extin-
guished responding and a significant effect of test was detected,
post hoc tests were conducted within each group comparing lever
pressing during extinction to that during test. All groups signifi-
cantly reinstated lever pressing (Veh-Ctrl, p 0.01; Cef-xCT AS,
p  0.01; Veh-xCT AS, p  0.0001) with the exception of the
Cef-Ctrl group (Fig. 1D), indicating that the knockdown of xCT
inhibits Cef from preventing reinstatement. As there was not a
significant test  group interaction for the data presented in
Figure 1D, we were not able to conclude that the lever pressing
during the cue-primed test was attenuated in the Cef-Ctrl group
relative to presses during this test in other groups. However, as
reinstatement of the drug-seeking response did not occur in Cef-
Ctrl rats (no difference between extinction and test), but did in
the other three groups, our interpretation is that Cef prevents
reinstatement. Rats did not increase responding on the inactive
lever during the reinstatement test, as no effect of test and no
group test interaction were detected (Fig. 1E). Figure 1F indi-
cates the unilateral cannulae placement for a subset of the 40 rats
used for this experiment.
Experiment 2: GLT-1 knockdown inhibits the prevention of
reinstatement by ceftriaxone
Rats self-administered cocaine and underwent extinction train-
ing and treatment with Cef or Veh as in Experiment 1 (Fig. 1A).
For Experiment 2, rats were infused with either Ctrl oligo or
antisense designed to prevent GLT-1 translation and administered
either Cef or Veh for 5 d. Before treatment, no group differences in
active lever pressing were present during self-administration (Fig.
2A). Presses on the inactive lever remained low throughout self-
administration and extinction (Fig. 2B).
A two-way RM ANOVA conducted on active lever pressing
during extinction and the cue-primed reinstatement test (Fig.
2C) indicated a significant effect of test (F(1,24)  58.73, p 
0.0001), group (F(3,24) 4.849, p 0.0089), and a test group
interaction (F(3,24) 6.053, p 0.0032). Post hoc tests comparing
extinction to test revealed that all groups significantly reinstated
lever pressing (Veh-Ctrl, p 0.001; Cef-GLT AS, p 0.01; Veh-
GLTAS, p 0.001)with the exception of theCef-Ctrl group (Fig.
2C), indicating that the knockdown of xCT inhibits Cef from
preventing reinstatement. Post hoc tests indicated that the Cef-
Ctrl group displayed a significantly lower number of active lever
presses during the test than the Veh-Ctrl (p 0.001), Veh-GLT
AS (p 0.0001), and Cef-GLT AS (p 0.01) groups. A signifi-
cant effect of test (F(1,24)  6.967, p  0.0144) was detected for
inactive lever pressing, as there was an overall decrease in inactive
lever pressing from extinction to test; however, post hoc tests did
not reveal differences between extinction and test for any group
(Fig. 2D).
Experiment3: surfaceandtotal expressionofglutamatereceptors
andtransporters followingGLT-1orxCTknockdown
To understand the potentially distinct NAc adaptations underly-
ing the ability of xCT andGLT-1 knockdown to prevent Cef from
attenuating reinstatement, we assessed protein expression of
GLT-1, xCT, and the AMPA receptor subunits GluA1 and GluA2
in a separate cohort of rats treated identically to those in Experi-
ments 1 and 2. No group differences in active lever pressing
were found during self-administration or extinction (Fig. 3A).
While the number of inactive lever presses was high on day 1 of
self-administration, the number declined and remained low
throughout self-administration and extinction training (Fig. 3B).
According to the timeline in Figure 1A, rats did not undergo a
reinstatement test but were killed via rapid decapitation without
anesthesia, the NAc was rapidly dissected, and surface and total
protein fractions were labeled and separated by surface biotiny-
lation. GLT-1 and xCT were blotted in the total fraction to con-
firm the ability of antisense treatment to decreaseGLT-1 and xCT
expression in rats receiving long-term ceftriaxone treatment. We
blotted for the GLT-1a splice variant as this is the predominant
isoform expressed in the rodent forebrain (Rimmele and Rosen-
berg, 2016) and was previously shown to be upregulated by Cef
(Rothstein et al., 2005). We also used an antibody that detects
both GLT-1a and GLT-1b splice variants by recognizing an
epitope on the shared N terminus; we report these results as
LaCrosse et al. • Ceftriaxone and the Role of xCT and GLT-1 Upregulation J. Neurosci., June 14, 2017 • 37(24):5809–5821 • 5813
“nGLT-1.” GluA1 and GluA2 were blot-
ted in both total and surface fractions as
GluA1 surface (but not total) expression is
increased by cocaine self-administration
while GluA2 is not, indicating the forma-
tion of GluA2-lacking AMPA receptors
(Conrad et al., 2008).
GLT-1a expression in the total protein
fraction differed by group (F(4,39) 6.886,
p 0.0003; Figure 3C). TheCoc-Veh-Ctrl
group displayed reduced GLT-1a ex-
pression compared with the Sal-Veh-
Ctrl group (p  0.05), confirming our
previous findings that cocaine self-ad-
ministration reduces GLT-1 expression in
the NAc (Knackstedt et al., 2010a). The
Coc-Cef-GLT-1 AS group also demon-
strated significantly reduced GLT-1a rela-
tive to Sal (p  0.05), indicating that the
knockdown of GLT-1 in the presence of
Cef treatment knocked down the GLT-1a
isoform. The Coc-Cef-xCT AS group dis-
played reduced GLT-1a expression rela-
tive to both the Sal (p  0.001) and the
Coc-Cef-Ctrl (p  0.01) groups, and so
the knockdown of xCT significantly re-
duced GLT-1a expression. The pattern of
nGLT-1 expression (data not shown) was
identical to that of GLT-1a, with expres-
sion differing by group (F(4,34)  7.309,
p  0.0002). The Coc-Cef-GLT-1 AS
group displayed reduced nGLT-1 relative
to Sal (p  0.05), indicating that the
knockdown of GLT-1 in the presence of
Cef treatment was effective. The Coc-Cef-
xCT AS group displayed reduced nGLT-1
expression relative to both the Sal (p 
0.001) and the Coc-Cef-Ctrl (p  0.01)
groups, and so the knockdown of xCT significantly reduced
GLT-1 expression, providing evidence of coregulation of xCT
and GLT-1 by ceftriaxone. The identical pattern of expression be-
tween the GLT-1a and nGLT-1 isoforms supports the idea that the
GLT-1a splice variant is the predominant variant in the forebrain
(for review, see Danbolt et al., 2016). It is also possible that GLT-1b
expression changes in the same pattern as GLT-1a. Unfortunately,
we did have sufficient tissue for blotting GLT-1b in these samples
after conducting theWestern blotting reported here.
The expression of xCT (Fig. 3D) differed by group (F(4,44) 
3.114, p 0.0243). Post hoc tests revealed that Coc-Cef-Ctrl rats
had increased xCT expression relative to both the Sal (p 0.001)
and Coc-Veh-Ctrl (p  0.001) groups, and this effect was re-
versed by xCT antisense infusion (Coc-Cef-Ctrl vs Coc-Cef-xCT
AS, p 0.0001). While the knockdown of GLT-1 did not signif-
icantly reduce xCT expression relative to Sal controls, it pre-
vented Cef from upregulating xCT, also providing evidence for
the coregulation of these transporters by Cef. Rats infused with
GLT-1 antisense and administered Cef displayed xCT expression
that did not differ from that in cocaine-naive rats, indicating that
the reinstatement of cocaine seeking in this group (Fig. 2C) can
be solely attributed to GLT-1 knockdown. Interestingly, xCT ex-
pression in the Coc-Veh-Ctrl group was not reduced (p 0.08)
relative to Sal controls, whereas we have previously demonstrated
it to be significantly lower (Knackstedt et al., 2010a). This differ-
ence may arise from the fact that here we blotted in total protein
lysates, whereas previously we blotted for xCT in a membrane-
enriched fraction.
We have previously shown that Cef reduces the potentiated
evoked and spontaneous EPSCs observed in the NAc following
cocaine self-administration and extinction (Trantham-Davidson
et al., 2012). Here, we had hypothesized that we would observe
increased GluA1 and GluA2 surface expression in the NAc of rats
administered cocaine that would be normalized by Cef. Surpris-
ingly, we found only increased GluA1, but not GluA2, surface
expression after cocaine administration (Fig. 3E,F), a pattern of
expression that indicates the formation of GluA2-lacking, calcium-
permeable (CP) AMPA receptors. A one-way ANOVA revealed a
significant effect for surface GluA1 expression (F(4,40) 5.252, p
0.0017), with increased expression in the Coc-Veh-Ctrl (p 0.01)
andCoc-Cef-xCTAS (p 0.05) groups relative to the Sal-Veh-Ctrl
group, as cocaine increased surface GluA1 and Cef treatment nor-
malized GluA1 (post hoc tests showed that this group did not differ
fromtheSal-Veh-Ctrl group).The ability ofCef tonormalizeGluA1
was prevented by xCT AS (Fig. 3E). Similar analyses of GluA1 total
protein expression did not detect a group effect (data not shown),
indicating that only trafficking to themembrane surface was altered
by cocaine and xCT knockdown. Surface GluA2 expression differed
by group (F(4,42) 3.518, p 0.0145), an effect driven by a signifi-
cant increase in the Coc-Cef-xCT AS group relative to the Sal-Veh-
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Figure 2. Self-administration, extinction, and reinstatement lever pressing in rats receiving intra-nucleus accumbens core AS
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Ctrl group (p  0.05; Fig. 3F). Similar analyses on total GluA2
expression detected a group effect (F(4,42) 3.316, p 0.019; data
not shown). Post hoc tests revealed a significant difference between
theSal-Veh-Ctrl and theCoc-Cef-Ctrl groups (p0.05), indicating
that ceftriaxone administered to rats administered cocaine reduces
GluA2 total protein expression.Thepresent results provide evidence
for the formation of GluA2-lacking AMPA receptors in the NAc
after cocaine self-administration, an effect previously demonstrated
in theNAcof rats after lengthy abstinence (without extinction) from
6h/dcocaine self-administration(Conradet al., 2008). Inagreement
with our previous study (LaCrosse et al., 2016), Cef prevented the
increase inGluA1 expression observed in rats administered cocaine.
This effect was prevented by xCT but not GLT-1 antisense. Interest-
ingly, xCT knockdown in the presence of Cef increased GluA2 sur-
face expression, while cocaine self-administration alone had no
effect on GluA2.
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Experiment 4: the effects of xCT and GLT-1 knockdown on
GluA1, GluA2, and GLT-1 expression in cocaine-naive rats
The pattern of GluA1 and GluA2 surface expression in Figure 3
indicates that the cocaine-induced shift to GluA2-lacking AMPA
receptors is not solely driven by decreased expression of xCT and
the consequent decrease in basal glutamate levels. Furthermore,
xCT knockdown resulted in a significant decrease in GLT-1 ex-
pression. Thus, we investigated whether xCT knockdown alone
would be sufficient to reproduce these patterns of protein expres-
sion in the absence of cocaine orCef.We infused xCTAS (n 12)
or Ctrl oligo (n 12) in the NAc of cocaine-naive rats and con-
ducted a biotinylation protocol on freshNAc tissue. Total protein
expression of GLT-1a was unaffected (Fig. 4A) as was expression
of nGLT-1, and surface expression of GLT-1a and nGLT-1 (data
not shown). In the total protein fraction, xCT was significantly
decreased by xCTknockdown (t(20) 2.362, p 0.0284; Fig. 4B).
Surface GluA1 expression was significantly increased by xCT
knockdown in cocaine-naive rats (t(20) 2.725, p 0.0130; Fig.
4C), while GluA1 in the total protein fraction was unaffected
(data not shown). Similarly, surface GluA2 expressionwas signif-
icantly increased by xCT knockdown in cocaine-naive rats
(t(19)  2.514, p  0.0211; Fig. 4D), while GluA2 in the total
protein fraction was unaffected (data not shown). Thus, a reduc-
tion in xCT level is sufficient to increase surface expression of
AMPA receptor subunits in the absence of a history of cocaine
exposure but does not favor the formation of CP-AMPA recep-
tors that lack the GluA2 subunit.
The data presented in Figure 3D indicate that while GLT-1
knockdown did not result in a significant decrease in xCT expres-
sion relative to either the Sal-Veh-Ctrl or Coc-Cef-Ctrl group, it
did prevent ceftriaxone fromupregulating xCT expression. Thus,
we infused GLT-1 AS into the NAc of cocaine-naive rats and
investigated the effects of GLT-1 knockdown on the proteins
assessed in Figure 3. We found that the GLT-1 knockdown was
effective at reducing nGLT-1 expression (t(6) 1.969, p 0.0482;
Fig. 5A) but had no effect on total xCT expression (Fig. 5B) in
drug-naive rats. Surface and total expression ofGluA1 andGluA2
were not altered (Fig. 5C,D for surface expression). Togetherwith
the results in Figure 4, the coregulation of xCT and GLT-1 ex-
pression observed in Figure 3 is only observed following ceftriax-
one treatment in rats with a history of cocaine exposure. It should
be noted that we did not include control conditions in which
cocaine-naive rats received ceftriaxone in combination with an-
tisense directed against either GLT-1 or xCT because our previ-
ous work (Knackstedt et al., 2010a) found that cocaine-naive rats
do not display changes in either protein when receiving the same
regimenof ceftriaxone treatmentusedhere.Thus, thismanipulation
wouldnotbepredicted toproducedifferent results than those found
here in Figures 4 and 5.
Experiment 5: knockdown of xCT in the nucleus accumbens
core reduces basal glutamate levels in cocaine-naive rats
In the NAc, the basal extracellular glutamate level is reduced by
60% upon infusion of Sxc inhibitors (Baker et al., 2002). Here we
sought to determine whether genetic knockdown of xCT would
have the same effect. Indeed, NAc basal extracellular glutamate
was reduced by xCT antisense in cocaine-naive rats (Fig. 6B). We
plotted glutamate infused into the NAc against the net flux of
glutamate (Fig. 6A). Using the point of y 0 to determine basal
glutamate levels, a decreased basal glutamate level was observed
in xCT antisense-infused rats relative to Ctrl animals (Fig. 6B;
t(12)  3.226, p  0.0073). Data from one Ctrl rat was excluded
for being 2 SDs from the average basal glutamate. A line of
regression was drawn through the four points; any rat with an r2
of80% was excluded (two from Ctrl group; one from xCT AS
group). The slope of the regression line was significantly reduced
following xCT AS infusion (F(1,68) 11.4177, p 0.0012), indi-
cating a potential decrease in glutamate reuptake. Thus, while we
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did not observe changes in total GLT-1 expression after xCT
knockdown (Fig. 4A), other adaptations in the transporter may
be occurring, such as changes in binding, activity, or placement in
the synapse. Furthermore, we can conclude that the upregulation
of GluA1 andGluA2 occurring after xCT knockdown (Fig. 4C,D)
is a consequence of decreased basal glutamate levels.
Experiment 6: GLT-1 mRNA expression is not significantly
altered by cocaine or ceftriaxone
The data presented in Figure 3 indicate that antisense-mediated
reduction in xCT protein expression significantly reduces
GLT-1a expression in rats treated with Cef, and antisense di-
rected at GLT-1 reduces the ability of Cef to upregulate xCT.
However, Cef was reported to increase rodent GLT-1 (Rothstein
et al., 2005) and xCTmRNA expression (Lewerenz et al., 2009) in
vitro. Because the results of Figure 3 indicate a coregulation of Cef
on xCT andGLT-1 protein expression, we investigated the effects
of cocaine and Cef treatment on GLT-1 and xCT mRNA expres-
sion. Cef has been shown to increase the protein expression of
two splice variants of GLT-1: GLT-1a and GLT-1b (Alhaddad et
al., 2014; Rao et al., 2015). Thus, we quantified both GLT-1a and
GLT-1bmRNA and protein expression here in the same animals.
Rats self-administered cocaine and were treated with either Cef
orVeh during extinction training, as shown in Figure 1A, without
antisense treatment. Before assignment to receive Cef or Veh,
there were no group differences in infusions (data not shown) or
active lever pressing during self-administration or extinction
training (Fig. 7A). Similarly, there was no effect of group on
inactive lever presses during self-administration (Fig. 7B). Fol-
lowing rapid decapitation, the NAc was dissected, and one hemi-
sphere was frozen for qPCR analysis and the other was frozen for
Western blotting. We found no significant group effects on total
GLT-1, GLT-1b, or xCTmRNA expression (Fig. 7C–E). Western
blotting for GLT-1a in the total protein fraction revealed a signif-
icant overall effect of group on GLT-1a expression (F(2,20) 
3.456, p 0.05; Fig. 7F). A significant effect of group on GLT-1b
expression was detected (F(2,25)  4.127, p  0.0283, Fig. 7G).
Post hoc tests revealed that the expression of GLT-1b in the Sal-
Veh group was significantly greater than that in the Coc-Veh
group (p 0.05). A one-way ANOVA conducted on xCT immu-
noreactivity (Fig. 7H) revealed a significant main effect of group
(F(2,20) 3.456, p 0.05), but post hoc tests did not reveal further
differences.
Western blotting for these proteinswas not conducted in sam-
ples from the Sal-Cef group, aswe previously have shown that Cef
is unable to increase the expression of these proteins in cocaine-
naive rats (Knackstedt et al., 2010a). Thus, the ability of both
cocaine and Cef to alter GLT-1 and xCT protein expression po-
tentially stems from translational and/or membrane-trafficking
modifications.
Experiment 7: coregulation of xCT and GLT-1 is not
accomplished through direct physical interaction
Both xCT and GLT-1 are downregulated following cocaine ad-
ministration, and long-term treatment with Cef increases their
expression. We sought to determine whether the ability of co-
caine and Cef to alter the expression of both proteins is due to
their physical interaction under these conditions. Thus, we
treated rats that had self-administered cocaine and undergone
extinction with Veh (n  2) or Cef (n  2) and did the same in
yoked-saline rats (n 2 for Veh and Cef treatment) according to
the timeline in shown in Figure 1A. A GLT-1 pulldown was con-
ducted on freshly dissected NAc tissue. Western blots against
nGLT-1 confirmed that we successfully immunoprecipitated
GLT-1 (Fig. 8A) and Na/K ATPase 3, a protein known to be
physically associated with GLT-1 (Genda et al., 2011; Fig. 8B).
xCT protein did not coimmunoprecipitate with GLT-1 under
any condition (Fig. 8C), confirming our previous finding in post-
mortem human prefrontal cortex (Shan et al., 2014).
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Figure 6. No-net-flux microdialysis revealed that basal extracellular glutamate is reduced
by intra-NAc infusion of xCT antisense.A, The concentration of glutamate perfusedwas plotted
against the net flux of glutamate. B, Computing the point of no net-flux across the dialysis
membrane in A and making a comparison between groups revealed that xCT antisense signif-
icantly reduced the basal glutamate level relative to the Ctrl group. C, Microdialysis probe tracks
through theNAc; representativeexamplesofdialysis probesaredepictedalong the rostrocaudal
axis of the NAc. *Indicates significant difference between groups ( p 0.05).
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Discussion
The present findings support important
and distinct roles for GLT-1 and xCT
in mediating the protective effects of
ceftriaxone on the NAc synapse and the
reinstatement of cocaine seeking. The
knockdown of xCT in the NAc prevented
Cef from attenuating reinstatement and
from normalizing GLT-1 and GluA1 lev-
els. Intra-NAc GLT-1 antisense also
prevented Cef from attenuating reinstate-
ment, an effect solely attributable to
GLT-1 knockdown as xCT, GluA1, and
GluA2 expression was not altered by
GLT-1 antisense relative to controls. The
knockdown of xCT in cocaine-naive rats
reduced basal extracellular glutamate lev-
els in the NAc and increased surface
GluA1 and GluA2 expression but did not
alter GLT-1 expression.
Regulation of relapse to cocaine seeking
by glutamate
The reinstatement of cocaine seeking is
accompanied by glutamate efflux (McFar-
land et al., 2003), and the infusion of an
mGluR2/3 agonist into the NAc core at-
tenuates reinstatement (Peters and Kali-
vas, 2006) by reducing glutamate efflux
during cue-primed reinstatement (Smith
et al., 2017). Reinstatement is also attenu-
ated by intra-NAc infusions of AMPA re-
ceptor (Famous et al., 2008), CP-AMPA
(White et al., 2016), and mGlu5 receptor antagonists (Wang et
al., 2013). Conversely, agonists to mGlu5 (Wang et al., 2013;
Schmidt et al., 2015) and AMPA receptors induce reinstatement
when infused into the NAc (Ping et al., 2008). Ceftriaxone and
N-acetylcysteine attenuate glutamate release during cocaine-
primed reinstatement, an effect attributed to the ability of both
compounds to increase xCT expression and Sxc function (Baker
et al., 2003; Trantham-Davidson et al., 2012). It is hypothesized
that increased nonsynaptic basal glutamate released by Sxc in-
creases tone on the presynaptic mGluR2/3 autoreceptors so that
action potential-dependent release can be regulated during the
reinstatement test. It is striking that reinstatement is not just
attenuated by long-termCef treatment but is prevented (Figs. 1D,
2C). We have replicated this effect in other ongoing, currently
unpublished, studies in our laboratory. We believe that this oc-
curs because not only does Cef attenuate presynaptic glutamate
release, it also increases GLT-1 and glutamate reuptake (Knack-
stedt et al., 2010a; Trantham-Davidson et al., 2012) to prevent
spillover of glutamate to the extrasynaptic mGlu5 receptors. Fur-
thermore, Cef reduces EPSC amplitude (Trantham-Davidson et
al., 2012) and surface GluA1 expression (Fig. 3), potentially re-
ducing CP-AMPA formation. Thus, Cef is able to prevent rein-
statement by reducing NAc medium-spiny neuron stimulation
from both AMPA and mGlu5 receptors.
The present data support an essential role for GLT-1 in medi-
ating the protective effects of Cef on reinstatement. GLT-1 likely
decreases the synaptic and extrasynaptic levels of glutamate dur-
ing reinstatement, limiting glutamate spillover and thus mGlu5
stimulation. We previously showed that NAc GLT-1 knock-
down increases cue-primed reinstatement of cocaine seeking in
N-acetylcysteine-treated rats, an effect prevented by a subthresh-
old infusion of an mGlu5 receptor antagonist into the NAc (Re-
issner et al., 2015). Our results are also consistent with the finding
that short-term intra-NAc treatment with a GLT-1 antagonist
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Figure 7. Nucleus accumbens core total protein andmRNA expression of GLT-1 isoforms following cocaine self-administration
and 2–3 weeks of extinction (Coc) or yoked-saline infusions (Sal). Cef or Veh treatment occurred during the last 6 d of extinction
training.A, Rats later assigned to receive Cef or Veh did not differ in active lever pressing during self-administration and extinction.
B, Inactive lever presses during self-administration and extinction. C–E, GLT-1 (C), GLT-1b (D), and xCT (E) mRNA expressionwere
not altered by either Coc or Cef. F–H, However, total protein expression of GLT-1a (F ), GLT-1b (G), and xCT (H ) in the sameanimals
was altered by Coc and Cef. *p 0.05 compared to Sal-Veh group; linewith * indicates significant ( p 0.05) effect of groupwith
one-way ANOVA.
Figure 8. GLT-1 and xCT are not physically associated with one another in the nucleus ac-
ccumbens core after cocaine or ceftriaxone administration. Rats self-administered cocaine or
received yoked saline infusions, underwent extinction training, and were treated with Veh or
Cef. A GLT-1 pulldown was conducted on freshly dissected NAc tissue. A, B, Western blots
against nGLT-1 confirmed that we successfully immunoprecipitated GLT-1 (A) and Na/K
ATPase3 (B), a protein known to be physically associated with GLT-1. C, xCT protein did not
immunoprecipitate with GLT-1 under any condition. Negative control, Immunoprecipitation
with an irrelevant antibody;3 (m),3 monomer;3 (d),3 dimer; S-V, yoked-saline plus
vehicle; C-V, cocaine plus vehicle; S-C, cocaine plus ceftriaxone; C-C, cocaine plus ceftriaxone.
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prevented Cef from attenuating cue-primed reinstatement (Fi-
scher et al., 2013).
Upregulation of xCT by Cef is essential to the ability of Cef to
attenuate reinstatement (Fig. 1).However, since xCTknockdown
prevented Cef from increasing GLT-1 expression, it is not clear
whether this behavioral effect is caused by decreased xCT or
GLT-1 expression. Furthermore, xCT upregulation is necessary
for Cef to reduce GluA1 surface expression, which likely contrib-
utes to the ability of Cef to prevent cue-primed reinstatement.
GluA2-lacking AMPA receptor formation after
cocaine self-administration
We found increased surface GluA1 expression and no change in
surface GluA2 expression following cocaine self-administration,
a pattern characteristic of CP-AMPA receptor formation (Liu
and Zukin, 2007). These receptors were first found after with-
drawal from long-access (LgA; 6 h/d) cocaine self-administration
without extinction (Conrad et al., 2008), and their presence in the
NAc was verified by an increased rectification index (RI). This
groupwent on to find that CP-AMPAs are found in theNAc after
long withdrawal (35 d) from LgA but not short-access (ShA; 2
h/d) cocaine self-administration (Purgianto et al., 2013). How-
ever, when extinction training is used following ShA cocaine self-
administration, there is evidence of CP-AMPA formation: the
CP-AMPA receptor antagonist Naspm attenuates cocaine-
primed reinstatement when infused into the NAc (White et al.,
2016). In agreement, here we find evidence for CP-AMPA forma-
tion after ShA cocaine self-administration and extinction train-
ing (Fig. 3E,F). However, evidence for increased RI following
ShA self-administration and extinction training is needed to
confirm CP-AMPA formation. Ceftriaxone normalized surface
GluA1 expression (Fig. 3E) through an unknownmechanism. As
mGluR1 stimulation decreases surface GluA1 expression (Mc-
Cutcheon et al., 2011; Loweth et al., 2014), it is possible that the
increase in nonsynaptic glutamate after long-term Cef treatment
stimulates mGluR1 to reduce surface GluA1.
Decreasing basal glutamate levels was not sufficient to in-
crease surface GluA1 expression relative to that of GluA2 (Figs. 4,
6). The observed increase in both AMPA receptor subunits ac-
companying decreased basal glutamate levels is in line with a
synaptic scaling effect. Synaptic scaling involves an upregulation
in GluA1 and GluA2 surface expression and increased miniature
EPSC amplitude following prolonged blockade of glutamate
transmission and has previously been reported in cultured cells
(O’Brien et al., 1998; Sun and Wolf, 2009). We are the first to
report such an effect in vivo after a manipulation to chronically
reduce glutamate levels. Thus, the formation of CP-AMPAs
following cocaine administration may be due to other pharma-
cological effects of cocaine self-administration or to extinction-
related learning.
Coregulation of xCT and GLT-1 expression by ceftriaxone
GLT-1 and xCT expression is decreased in the NAc after admin-
istration of cocaine (Knackstedt et al., 2010a) and nicotine
(Knackstedt et al., 2009). Ceftriaxone elevates both xCT and
GLT-1 following administration of cocaine (Knackstedt et al.,
2010a) and alcohol (Alhaddad et al., 2014). Evidence for func-
tional coregulation of the transporters also exists: the depletion of
intracellular glutamate inhibits Sxc export of glutamate (Bannai,
1986). In non-neuronal cells, glutamate taken up by glutamate
transporters activates Sxc to export glutamate (Rimaniol et al.,
2001). Excess accumulation of glutamate in the extracellular
space decreases Sxc activity (Murphy et al., 1989), indicating that
a homeostatic mechanism exists to balance extracellular gluta-
mate release and reuptake. However, we found that in the ab-
sence of a history of cocaine or ceftriaxone administration, the
knockdown of GLT-1 or xCT was not capable of altering the
protein expression of the other protein. We found evidence for
reduced glutamate clearance upon knockdown of xCT (Fig. 6),
and thus it is possible that a reduction in GLT-1 function was
present in this condition.
We found no evidence that Cef exerts coregulation of the
transporters via a transcriptional mechanism as there was no
effect of Cef on the mRNA product of either gene (Fig. 7). This
indicates that the expression of xCT and GLT-1 is coregulated by
ceftriaxone via a translational or traffickingmechanism. Previous
reports found ceftriaxone-induced upregulation of GLT-1
(Rothstein et al., 2005) and xCT (Lewerenz et al., 2009) in cell
cultures that were continuously treated with Cef, while here we
assessed mRNA levels 24 h following the last Cef injection. Thus,
it is also possible that a brief Cef-induced increase inmRNA leads
to a stable increase in protein product. Support for this hypoth-
esis comes from a report that GLT-1 mRNAwas not upregulated
in the dorsal striatumof ischemic rats administeredCef and killed
several days after the last Cef injection; however, protein expres-
sion was upregulated at this time (Krzyzanowska et al., 2016).
Further support for the idea that cocaine/Cef administration al-
ters xCT trafficking is the presence of relativelymodest changes in
xCT expression (Figs. 3D, 7H) in the total protein fraction, where
we have previously reported robust changes in a membrane-
enriched fraction (Knackstedt et al., 2010a).
An alternative mechanism of coregulation of xCT and GLT-1
could be that changes in intracellular or extracellular levels of
glutamate after cocaine/Cef administration could alter the ex-
pression or function of other transporters. Decreased basal levels
of extrasynaptic glutamate in cocaine-naive rats did not result in
changes in GLT-1 expression (Figs. 4, 6). It is possible that a
history of exposure to cocaine and/or Cef is necessary tomake the
NAc sensitive to this coregulation, perhaps by facilitating the
physical association of the transporters. To explore this possibil-
ity, we immunoprecipitated GLT-1 in both cocaine and saline
self-administering rats treated with Cef or Veh and found no
evidence that xCT and GLT-1 are in physical contact in any con-
dition (Fig. 8).
In conclusion, we have identified both xCT and GLT-1 up-
regulation as being essential for the ability of Cef to attenuate
cue-primed reinstatement of cocaine seeking.We found evidence
for coregulation of the expression of these transporters in the
presence of both Cef and cocaine, possibly via trafficking or
translational mechanisms. While we did not identify a mecha-
nism underlying this coregulation, our findings support previous
work that found evidence for functional coregulation, and future
work will examine the molecular mechanisms by which Cef ex-
erts regulation of xCT and GLT-1 expression. Furthermore, we
found that decreasing xCT expression decreases basal glutamate
levels in the NAc and leads to compensatory increases in surface
GluA1 and GluA2 expression, a result that extends and confirms
previouswork performed in cell cultures.While these data clearly
show a functional relationship between glutamate homeostasis
and ionotropic glutamate receptor trafficking, increased surface
GluA1 anddecreasedGLT-1 expression after cocaine administra-
tion cannot be solely attributed to decreased basal glutamate lev-
els in the NAc.
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